Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density

Jong-Wook Seo; Dong-Yun Lee; Dong‐Yun Lee; Byung-Koo Yoon; DooSeok Choi

doi:10.1016/j.ejogrb.2017.03.011

Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density

Jong-Wook Seo, Dong-Yun Lee, Dong‐Yun Lee, Byung-Koo Yoon, DooSeok Choi

European journal of obstetrics, gynecology, and reproductive biology · 2017 · vol. 212 , pp. 9–12 · doi:10.1016/j.ejogrb.2017.03.011 · PMID:28314166 · W2591855704

article OA: closed CC0 ⤵ 32 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the impact of extended postoperative dienogest treatment for endometriosis on bone mineral density in patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Bone Density Contraceptives, Oral Endometriosis Nandrolone Absorptiometry, Photon Adult Bone Density Contraceptives, Oral Contraceptives, Oral Contraceptives, Oral Endometriosis Endometriosis Female Femur Neck Femur Neck Femur Neck Humans Lumbar Vertebrae Lumbar Vertebrae Lumbar Vertebrae

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

ACOG Committee Opinion #310: Endometriosis in Adolescents via openalex
A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
Current Strategies for Endometriosis Management via openalex
Dienogest via openalex
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
Endometriosis in Adolescents via openalex
Evaluation and treatment of endometriosis. via openalex
Incidence of Laparoscopically Confirmed Endometriosis by Demographic, Anthropometric, and Lifestyle Factors via openalex
Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex
Long-Term Administration of Dienogest Reduces Recurrence after Excision of Endometrioma via openalex
Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women via openalex
Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence via openalex
Postoperative Medical Therapy After Surgical Treatment of Endometriosis: From Adjuvant Therapy to Tertiary Prevention via openalex
Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
W6704180603 via openalex
W1997810509 via openalex
W2045458073 via openalex
W2101417341 via openalex
W18374401 via openalex

Cited by (32)

Source provenance

europepmc: last seen: 2026-06-11T06:19:48.454388+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:20:31.759405+00:00

License: CC0 · commercial use OK

[1] ACOG Committee Opinion #310: Endometriosis in Adolescents via openalex

[2] A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex

[3] Current Strategies for Endometriosis Management via openalex

[4] Dienogest via openalex

[5] Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex

[6] Endometriosis in Adolescents via openalex

[7] Evaluation and treatment of endometriosis. via openalex

[8] Incidence of Laparoscopically Confirmed Endometriosis by Demographic, Anthropometric, and Lifestyle Factors via openalex

[9] Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex

[10] Long-Term Administration of Dienogest Reduces Recurrence after Excision of Endometrioma via openalex

[11] Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women via openalex

[12] Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence via openalex

[13] Postoperative Medical Therapy After Surgical Treatment of Endometriosis: From Adjuvant Therapy to Tertiary Prevention via openalex

[14] Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex

[15] Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex

[16] Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex

[17] W6704180603 via openalex

[18] W1997810509 via openalex

[19] W2045458073 via openalex

[20] W2101417341 via openalex

[21] W18374401 via openalex